Product Recommendations NGAL- Early Marker of Acute Kidney Injury

What is NGAL? The full name of NGAL is human lipocalin 2 (Ln2) or siderocalin. It belongs to the lipocalin family and is the earliest proposed marker of acute kidney injury (AKI).   What is the clinical significance of NGAL? 1. NGAL is a marker of acute kidney injury (AKI) When AKI occurs

Emerging early diagnostic methods for acute kidney injury

Novel biomarkers of acute kidney injury and failure: clinical applicability - British Journal of Anaesthesia

Biomarkers for acute kidney injury: is NGAL ready for clinical use?

NGAL - Bioporto

Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients, Critical Care

Rule Out Acute Kidney Injury in the Emergency Department With a Urinary Dipstick - ScienceDirect

Acute kidney injury Nature Reviews Disease Primers

Product Recommendations NGAL- Early Marker of Acute Kidney Injury

Frontiers Predictive value of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis

Emerging early diagnostic methods for acute kidney injury

Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference - ScienceDirect